Pavmed Series Z Stock Cash Per Share

PAVMZ Stock  USD 0.03  0.00  0.00%   
PAVmed Series Z fundamentals help investors to digest information that contributes to PAVmed Series' financial success or failures. It also enables traders to predict the movement of PAVmed Stock. The fundamental analysis module provides a way to measure PAVmed Series' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PAVmed Series stock.
Last ReportedProjected for Next Year
Cash Per Share 3.09  3.58 
Cash Per Share is likely to rise to 3.58 in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

PAVmed Series Z Company Cash Per Share Analysis

PAVmed Series' Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Current PAVmed Series Cash Per Share

    
  3.58  
Most of PAVmed Series' fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PAVmed Series Z is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

PAVmed Cash Per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for PAVmed Series is extremely important. It helps to project a fair market value of PAVmed Stock properly, considering its historical fundamentals such as Cash Per Share. Since PAVmed Series' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of PAVmed Series' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of PAVmed Series' interrelated accounts and indicators.
0.3-0.58-0.660.750.451.00.790.780.7-0.66-0.160.810.610.820.670.820.810.210.780.870.21-0.43
0.3-0.940.51-0.28-0.70.380.470.1-0.260.180.720.790.93-0.23-0.44-0.23-0.26-0.74-0.290.38-0.740.7
-0.58-0.94-0.220.00.45-0.65-0.6-0.310.010.04-0.52-0.92-1.0-0.080.17-0.09-0.040.52-0.03-0.650.52-0.45
-0.660.51-0.22-0.92-0.97-0.6-0.35-0.66-0.860.760.74-0.110.18-0.91-0.96-0.9-0.92-0.77-0.91-0.5-0.770.92
0.75-0.280.0-0.920.860.720.570.880.96-0.91-0.590.340.020.840.950.840.820.580.80.570.58-0.72
0.45-0.70.45-0.970.860.390.20.560.8-0.72-0.8-0.12-0.420.780.930.780.810.80.80.270.8-0.95
1.00.38-0.65-0.60.720.390.790.780.67-0.64-0.130.850.670.770.620.770.750.150.730.90.15-0.35
0.790.47-0.6-0.350.570.20.790.80.57-0.610.250.850.60.480.450.480.52-0.260.380.47-0.26-0.16
0.780.1-0.31-0.660.880.560.780.80.86-0.92-0.210.610.310.640.730.640.620.190.560.570.19-0.39
0.7-0.260.01-0.860.960.80.670.570.86-0.88-0.540.320.010.780.930.780.760.540.740.530.54-0.67
-0.660.180.040.76-0.91-0.72-0.64-0.61-0.92-0.880.41-0.37-0.05-0.67-0.8-0.67-0.65-0.41-0.63-0.46-0.410.54
-0.160.72-0.520.74-0.59-0.8-0.130.25-0.21-0.540.410.350.48-0.48-0.63-0.48-0.49-0.8-0.55-0.25-0.80.74
0.810.79-0.92-0.110.34-0.120.850.850.610.32-0.370.350.920.360.170.360.34-0.360.280.72-0.360.15
0.610.93-1.00.180.02-0.420.670.60.310.01-0.050.480.920.11-0.150.110.07-0.50.060.68-0.50.42
0.82-0.23-0.08-0.910.840.780.770.480.640.78-0.67-0.480.360.110.91.00.970.680.990.680.68-0.78
0.67-0.440.17-0.960.950.930.620.450.730.93-0.8-0.630.17-0.150.90.90.880.710.870.460.71-0.85
0.82-0.23-0.09-0.90.840.780.770.480.640.78-0.67-0.480.360.111.00.90.970.680.990.680.68-0.78
0.81-0.26-0.04-0.920.820.810.750.520.620.76-0.65-0.490.340.070.970.880.970.60.970.60.6-0.86
0.21-0.740.52-0.770.580.80.15-0.260.190.54-0.41-0.8-0.36-0.50.680.710.680.60.730.271.0-0.75
0.78-0.29-0.03-0.910.80.80.730.380.560.74-0.63-0.550.280.060.990.870.990.970.730.680.73-0.82
0.870.38-0.65-0.50.570.270.90.470.570.53-0.46-0.250.720.680.680.460.680.60.270.680.27-0.22
0.21-0.740.52-0.770.580.80.15-0.260.190.54-0.41-0.8-0.36-0.50.680.710.680.61.00.730.27-0.75
-0.430.7-0.450.92-0.72-0.95-0.35-0.16-0.39-0.670.540.740.150.42-0.78-0.85-0.78-0.86-0.75-0.82-0.22-0.75
Click cells to compare fundamentals

PAVmed Cash Per Share Historical Pattern

Today, most investors in PAVmed Series Stock are looking for potential investment opportunities by analyzing not only static indicators but also various PAVmed Series' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's cash per share growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of PAVmed Series cash per share as a starting point in their analysis.
   PAVmed Series Cash Per Share   
       Timeline  
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Competition

PAVmed Common Stock Shares Outstanding

Common Stock Shares Outstanding

7.62 Million

At this time, PAVmed Series' Common Stock Shares Outstanding is fairly stable compared to the past year.

PAVmed Cash Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PAVmed Series' direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PAVmed Series could also be used in its relative valuation, which is a method of valuing PAVmed Series by comparing valuation metrics of similar companies.
PAVmed Series is currently under evaluation in cash per share category among its peers.

PAVmed Series Current Valuation Drivers

We derive many important indicators used in calculating different scores of PAVmed Series from analyzing PAVmed Series' financial statements. These drivers represent accounts that assess PAVmed Series' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of PAVmed Series' important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap30.8M21.4M100.6M42.8M29.8M57.7M
Enterprise Value31.3M21.1M98.3M39.6M58.9M62.0M

PAVmed Fundamentals

About PAVmed Series Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze PAVmed Series Z's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PAVmed Series using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PAVmed Series Z based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for PAVmed Stock Analysis

When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.